Health / Medical Topics

    Buprenorphine Transdermal Matrix Patch

    A transdermal matrix patch containing the synthetic opioid buprenorphine with analgesic and sedative activities. Buprenorphine binds to and activates the mu-opioid receptors in the central nervous system (CNS), thereby mimicking the effects of the endogenous opiates. Binding to opioid receptors stimulates exchange of GTP for GDP, inhibits adenylate cyclase, and decreases intracellular cAMP. This inhibits the release of various nociceptive neurotransmitters, such as substance P, gamma-aminobutyric acid (GABA), dopamine, acetylcholine, noradrenaline, vasopressin, and somatostatin. In addition, buprenorphine closes N-type voltage-gated calcium channels and opens calcium-dependent inwardly rectifying potassium channels, resulting in hyperpolarization, reduced neuronal excitability, analgesia and sedation. Buprenorphine is a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor in the CNS. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    The determination of the amount of buprenorphine present in a sample.
    The hydrochloride salt form of buprenorphine, a synthetic phenanthrene with narcotic analgesic activity. Buprenorphine hydrochloride is a partial agonist at the mu-opioid…
    A drug used to relieve pain by blocking signals at nerve endings. It is being studied in the relief of pain following…
    A drug used to relieve pain by blocking signals at nerve endings. It is being studied in the relief of pain following…
    A therapeutic surgical procedure to remove a bunion.
    An electrocardiographic finding of ventricular tachycardia incorporating both bundle branches into the reentry circuit.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact